Human Alpha Galactosidases Transiently Produced in Nicotiana benthamiana Leaves: New Insights in Substrate Specificities with Relevance for Fabry Disease-Reference-Cited by-同舟云学术

Human Alpha Galactosidases Transiently Produced in Nicotiana benthamiana Leaves: New Insights in Substrate Specificities with Relevance for Fabry Disease

Published:2017-06-21 Issue: Volume:8 Page:
ISSN:1664-462X
Container-title:Frontiers in Plant Science
language:
Short-container-title:Front. Plant Sci.

Author:

Kytidou Kassiani,Beenakker Thomas J. M.,Westerhof Lotte B.,Hokke Cornelis H.,Moolenaar Geri F.,Goosen Nora,Mirzaian Mina,Ferraz Maria J.,de Geus Mark,Kallemeijn Wouter W.,Overkleeft Herman S.,Boot Rolf G.,Schots Arjen,Bosch Dirk,Aerts Johannes M. F. G.

Publisher

Frontiers Media SA

Subject

Plant Science

Reference56 articles.

1. Elevated globotriaosylsphingosine is a hallmark of Fabry disease.;Aerts;Proc. Natl. Acad. Sci. U.S.A.,2008

2. Therapeutic response to intravenous infusions of glucocerebrosidase in a patient with Gaucher disease.;Barton;Proc. Natl. Acad. Sci. U.S.A.,1990

3. Structural organization of the human alpha-galactosidase A gene: further evidence for the absence of a 3’ untranslated region.;Bishop;Proc. Natl. Acad. Sci. U.S.A.,1988

4. Recombinant enzyme therapy for fabry disease: absence of editing of human α-galactosidase A mRNA.;Blom;Am. J. Hum. Genet.,2003

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A theoretical study on binding and stabilization of galactose and novel galactose analogues to the human α-galactosidase A variant causing Fabry disease;Biophysical Chemistry;2023-01

2. Unraveling the effect of A143T, P205T and D244N mutations in α-galactosidase A on its catalytic activity and susceptibility to globotriaosylceramide and iminosugar 1-deoxygalactonojirimycin chaperone;Journal of Molecular Liquids;2022-05

3. Enzyme Replacement Therapy for Genetic Disorders Associated with Enzyme Deficiency;Current Medicinal Chemistry;2022-01

4. Medicinal Plants: Guests and Hosts in the Heterologous Expression of High-Value Products;Planta Medica;2021-09-14

5. Fabry Disease: Molecular Basis, Pathophysiology, Diagnostics and Potential Therapeutic Directions;Biomolecules;2021-02-12